Masaaki Toda

7.8k total citations · 2 hit papers
194 papers, 6.1k citations indexed

About

Masaaki Toda is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Masaaki Toda has authored 194 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Organic Chemistry, 56 papers in Molecular Biology and 51 papers in Pharmacology. Recurrent topics in Masaaki Toda's work include Inflammatory mediators and NSAID effects (33 papers), Asthma and respiratory diseases (24 papers) and Chemical synthesis and alkaloids (14 papers). Masaaki Toda is often cited by papers focused on Inflammatory mediators and NSAID effects (33 papers), Asthma and respiratory diseases (24 papers) and Chemical synthesis and alkaloids (14 papers). Masaaki Toda collaborates with scholars based in Japan, United States and Australia. Masaaki Toda's co-authors include Shimon Sakaguchi, Noriko Sakaguchi, Takamune Takahashi, M Iwata, Jun Shimizu, M Itoh, Yuhshi Kuniyasu, Hisao Nakai, Hideo Yamagishi and Esteban C. Gabazza and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Masaaki Toda

190 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

1998 1.3k citations Takamune Takahashi, Yuhshi Kuniyasu et al. International Immunology profile →
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.

1996 1.1k citations Masaaki Toda, Shimon Sakaguchi et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masaaki Toda Japan	31	3.1k	1.2k	988	704	565	194	6.1k
Don E. Griswold United States	40	2.0k 0.6×	2.4k 2.0×	785 0.8×	1.2k 1.7×	1.2k 2.1×	120	6.4k
Yi Liu China	34	1.1k 0.3×	2.1k 1.8×	490 0.5×	667 0.9×	357 0.6×	184	4.7k
Bernard Weill France	41	1.5k 0.5×	1.6k 1.3×	192 0.2×	645 0.9×	374 0.7×	132	5.5k
Carole Nicco France	37	1.3k 0.4×	2.2k 1.8×	316 0.3×	612 0.9×	249 0.4×	107	5.2k
Paolo Carminati Italy	37	1.0k 0.3×	1.9k 1.6×	553 0.6×	689 1.0×	236 0.4×	115	4.4k
Henry J. Showell United States	39	2.8k 0.9×	2.4k 2.0×	172 0.2×	1.2k 1.7×	999 1.8×	86	6.1k
Marcello Allegretti Italy	34	1.2k 0.4×	909 0.8×	318 0.3×	988 1.4×	353 0.6×	116	3.6k
John M. Sanders United States	37	835 0.3×	1.6k 1.3×	402 0.4×	501 0.7×	251 0.4×	71	4.0k
Guy Laurent France	49	1.5k 0.5×	3.9k 3.3×	237 0.2×	1.8k 2.6×	554 1.0×	197	7.3k
M. Micksche Austria	47	1.2k 0.4×	2.7k 2.3×	407 0.4×	1.9k 2.7×	239 0.4×	187	6.0k

Countries citing papers authored by Masaaki Toda

Since Specialization

Citations

This map shows the geographic impact of Masaaki Toda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Toda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Toda more than expected).

Fields of papers citing papers by Masaaki Toda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Toda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Toda. The network helps show where Masaaki Toda may publish in the future.

Co-authorship network of co-authors of Masaaki Toda

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Toda. A scholar is included among the top collaborators of Masaaki Toda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Toda. Masaaki Toda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oda, Keiko, Kan Katayama, Liqing Zang, et al.. (2024). The Protective Role of KANK1 in Podocyte Injury. International Journal of Molecular Sciences. 25(11). 5808–5808. 1 indexed citations

Wu, Jing, Junhong Wang, Jae‐Hoon Choi, et al.. (2023). Bioactive Compounds from the Mushroom-Forming Fungus Chlorophyllum molybdites. Antibiotics. 12(3). 596–596. 5 indexed citations

Yasuma, Taro, Masaaki Toda, Ahmed M. Abdel-Hamid, et al.. (2021). Degradation Products of Complex Arabinoxylans by Bacteroides intestinalis Enhance the Host Immune Response. Microorganisms. 9(6). 1126–1126. 32 indexed citations

Kobayashi, Tetsu, Corina N. D’Alessandro‐Gabazza, Hajime Fujimoto, et al.. (2018). Mice overexpressing latent matrix metalloproteinase-2 develop lung emphysema after short-term exposure to cigarette smoke extract. Biochemical and Biophysical Research Communications. 497(1). 332–338. 9 indexed citations

Toda, Masaaki, Taro Yasuma, Rumi Mifuji‐Moroka, et al.. (2017). Low dose of alcohol attenuates pro-atherosclerotic activity of thrombin. Atherosclerosis. 265. 215–224. 8 indexed citations

D’Alessandro‐Gabazza, Corina N., Masaaki Toda, Taro Yasuma, et al.. (2017). The Medicinal Mushroom, Grifola gargal , Ameliorates Allergic Bronchial Asthma. Journal of Medicinal Food. 21(2). 136–145. 2 indexed citations

D’Alessandro‐Gabazza, Corina N., Masaaki Toda, Taro Yasuma, et al.. (2015). Amelioration of Atherosclerosis by the New Medicinal Mushroom Grifola gargal Singer. Journal of Medicinal Food. 18(8). 872–881. 13 indexed citations

Naito, Masahiro, Osamu Taguchi, Tetsu Kobayashi, et al.. (2013). Thrombin-Activatable Fibrinolysis Inhibitor Protects against Acute Lung Injury by Inhibiting the Complement System. American Journal of Respiratory Cell and Molecular Biology. 49(4). 646–653. 23 indexed citations

Toda, Masaaki, Zhifei Shao, Ken Yamaguchi, et al.. (2013). Differential Gene Expression in Thrombomodulin (TM; CD141)+ and TM− Dendritic Cell Subsets. PLoS ONE. 8(8). e72392–e72392. 11 indexed citations

10.

Sakaguchi, Shimon, Noriko Sakaguchi, Masanao Asano, Misako Itoh, & Masaaki Toda. (2011). Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995.. PubMed. 186(7). 3808–21. 107 indexed citations

11.

Obitsu, Tetsuo, Takashi Kondo, Naoya Matsumura, et al.. (2011). 6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists. Bioorganic & Medicinal Chemistry. 19(18). 5432–5445. 19 indexed citations

12.

Takagi, Takehiro, Osamu Taguchi, Masaaki Toda, et al.. (2010). Inhibition of Allergic Bronchial Asthma by Thrombomodulin Is Mediated by Dendritic Cells. American Journal of Respiratory and Critical Care Medicine. 183(1). 31–42. 39 indexed citations

13.

Gil-Bernabe, Paloma, Corina N. D’Alessandro‐Gabazza, Y. Matsuda, et al.. (2010). High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double‐deficient mice. Journal of Thrombosis and Haemostasis. 8(11). 2514–2522. 8 indexed citations

14.

Wang, Linan, Kanako Saito, Masaaki Toda, et al.. (2009). UV irradiation after immunization induces type 1 regulatory T cells that suppress Th2-type immune responses via secretion of IL-10. Immunobiology. 215(2). 124–132. 13 indexed citations

15.

Maruyama, Toru, Toru Maruyama, Masaki Asada, et al.. (2002). Design and synthesis of a selective EP4-Receptor agonist. Part 1: discovery of 3,7-DithiaPGE1 derivatives and identification of Their ω chains. Bioorganic & Medicinal Chemistry. 10(4). 975–988. 4 indexed citations

16.

Maruyama, Toru, Toru Maruyama, Masaki Asada, et al.. (2002). Design and Synthesis of a Selective EP4-Receptor Agonist. Part 2: 3,7-DithiaPGE1 Derivatives with High Selectivity. Bioorganic & Medicinal Chemistry. 10(4). 989–1008. 11 indexed citations

17.

Maruyama, Toru, Toru Maruyama, Shin‐itsu Kuwabe, et al.. (2002). Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist. Bioorganic & Medicinal Chemistry. 10(7). 2103–2110. 21 indexed citations

18.

Maruyama, Toru, Masaki Asada, Tai Shiraishi, et al.. (2001). Design and synthesis of a highly selective EP4-receptor agonist. part 1: 3,7-dithiaPG derivatives with high selectivity. Bioorganic & Medicinal Chemistry Letters. 11(15). 2029–2031. 18 indexed citations

19.

Takahashi, Takamune, Yuhshi Kuniyasu, Masaaki Toda, et al.. (1998). Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.. International Immunology. 10(12). 1969–1980. 1265 indexed citations breakdown →

20.

Toda, Masaaki, et al.. (1996). Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.. The Journal of Experimental Medicine. 184(2). 387–396. 1064 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact